A pharmaceutically acceptable salt of an arylvinlazacycloalkane compound

Abstract

A pharmaceutically acceptable salt of a compound of Formula (I) is disclosed. The compound is ligand of various nAChRs. The pharmaceutically acceptable salt of the compound can be used to prepare pharmaceutical composition and / or medicament intended to prevent or treat disorders associated with dysfunction of nAChRs, especially within the central nervous system or the gastrointestinal system. Examples of types of disorders that can be treated include neurodegenerative disorders, including central nervous system disorders such as Alzheimer's disease, cognitive disorders, motor disorders such as Parkinson's disease, drug addiction, behavioral disorders an inflammatory disorders within the gastrointestinal system. The salts of the compound can also serve as analgesics in the treatment of acute, chronic or recurrent pain.